Money Talks: Why weight-loss drugs will reshape the world
Money Talks from The Economist
00:00
The Economic Impact of Obesity and Weight-Loss Medications
Exploring the significant economic costs of obesity on both medical care and labor market outcomes, this chapter delves into the association between obesity and chronic diseases like diabetes and cardiovascular issues. It also discusses the emergence of weight-loss drugs in the market, their costs, and potential economic benefits, envisioning a future where such medications are widely accessible. The conversation touches on societal perceptions of body image, concerns about health equity, and potential shifts in global economic systems due to the widespread use of weight-loss medications.
Transcript
Play full episode
